Chimeric Therapeutics Ltd
OTC:CHMMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chimeric Therapeutics Ltd
OTC:CHMMF
|
AU |
|
Sulzer AG
OTC:SULZF
|
CH |
|
H
|
Hellenic Telecommunications Organization SA
ATHEX:HTO
|
GR |
|
C
|
Civil Engineering PCL
SET:CIVIL
|
TH |
|
T
|
TRC Construction PCL
SET:TRC
|
TH |
|
M
|
MCOT PCL
SET:MCOT
|
TH |
|
Airports of Thailand PCL
SET:AOT
|
TH |
|
S
|
Susco PCL
SET:SUSCO
|
TH |
|
Collective Metals Inc
F:TO1
|
CA |
|
C
|
Charoong Thai Wire & Cable PCL
SET:CTW
|
TH |
|
A
|
Alpha Pro Tech Ltd
F:APL
|
CA |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Chimeric Therapeutics Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Chimeric Therapeutics Does
Chimeric Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies.
- Headquarters
- Australia AU
- IPO date
- Jan 18, 2021
